[2] 刘长文,王剑荣,胡炜,等.综合重症监护病房细菌耐药性变迁[J].中国感染与化疗杂志,2010,10(4):281-284.
[2] Prabaker K,Weinstein RA.Trends in antimicrobial resistance in intensive care units in the United States[J].Curr Opin Crit Care,2011,17(5):472-479.
[3] 周华,皮博睿,俞云松.多重耐药鲍曼不动杆菌的挑战[J].现代实用医学,2009,21(1):4,44.
[4] 少朋,邵海枫,李珍大.舒巴坦单剂对鲍曼不动杆菌的体外抑菌活性研究[J].临床检验杂志,2004,22(5):349-351.
[5] 沈继录,吴卫红,朱德妹.美罗培南耐药铜绿假单胞菌多药外排泵研究[J].中国感染与化疗杂志,2011,11(6):446-451.
[6] Clinical and Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2009,M100-S19.
[7] Sander P,Belova L,Kidan YG.Ribosomal and non-Ribosomal resistance to Oxazolidinones:species-specific Idiosyncrasy of Ribosomal alterations[J].Mol Microbiol,2002,46(5):1295-1304.
[8] 中华医学会重症医学分会.重症患者侵袭性真菌感染诊断与治疗指南(2007)[J].中华内科杂志,2007,46(11):960-966.
[9] 刘静媛,李红宾,祈文瑾.真菌对抗真菌药物耐药机制的研究进展[J].皮肤病与性病,2010,32(1):23-25.